Half-year report · Q2
3645.TEDINET S100V2YB
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.9bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Operating income | ¥48m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Ordinary income | ¥67m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥323m | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥59m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥17m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Total assets | ¥4.4bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥4.0bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2024-11-30 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥56m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥120m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥285m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥21m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.89 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.66 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.5% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-06-01 → 2024-11-30 | ¥908,000 |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥219m |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥219m |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥41m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥546m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥546m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥279m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥87m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥87m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥11m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥19m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥19m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥104m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥287m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2024-11-30 | ¥288m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Gain on forfeiture of unclaimed dividends noi | Prior1YTDDuration | 45000 | JPY |
| Gain on forfeiture of unclaimed dividends noi | CurrentYTDDuration | 240000 | JPY |
| Point return income noi | Prior1YTDDuration | － | JPY |
| Point return income noi | CurrentYTDDuration | 5205000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 25189000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 21661000 | JPY |
| Other noi | Prior1YTDDuration | 1892000 | JPY |
| Other noi | CurrentYTDDuration | 1950000 | JPY |
| Non operating income | Prior1YTDDuration | 27836000 | JPY |
| Non operating income | CurrentYTDDuration | 30884000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 2170000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 5929000 | JPY |
| Provision of allowance for doubtful accounts noe | Prior1YTDDuration | 1376000 | JPY |
| Provision of allowance for doubtful accounts noe | CurrentYTDDuration | － | JPY |
| Consumption tax difference noe | Prior1YTDDuration | － | JPY |
| Consumption tax difference noe | CurrentYTDDuration | 4848000 | JPY |
| Other noe | Prior1YTDDuration | 28000 | JPY |
| Other noe | CurrentYTDDuration | 407000 | JPY |
| Non operating expenses | Prior1YTDDuration | 3574000 | JPY |
| Non operating expenses | CurrentYTDDuration | 11185000 | JPY |
| Ordinary income | Prior1YTDDuration | 194049000 | JPY |
| Ordinary income | CurrentYTDDuration | 67303000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 2552000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | － | JPY |
| Extraordinary income | Prior1YTDDuration | 2552000 | JPY |
| Extraordinary income | CurrentYTDDuration | － | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 4269000 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | － | JPY |
| Impairment loss el | Prior1YTDDuration | － | JPY |
| Impairment loss el | CurrentYTDDuration | 1785000 | JPY |
| Restoration cost el | Prior1YTDDuration | － | JPY |
| Restoration cost el | CurrentYTDDuration | 4389000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | － | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 214000 | JPY |
| Other el | Prior1YTDDuration | － | JPY |
| Other el | CurrentYTDDuration | 2089000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 4269000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 8478000 | JPY |
| Income before income taxes | Prior1YTDDuration | 192331000 | JPY |
| Income before income taxes | CurrentYTDDuration | 58825000 | JPY |
| Income taxes current | Prior1YTDDuration | 73629000 | JPY |
| Income taxes current | CurrentYTDDuration | 62997000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -7728000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -5581000 | JPY |
| Income taxes | Prior1YTDDuration | 65901000 | JPY |
| Income taxes | CurrentYTDDuration | 57415000 | JPY |
| Profit loss | Prior1YTDDuration | 126430000 | JPY |
| Profit loss | CurrentYTDDuration | 1410000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 10658000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 18449000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |